UNAIDS out of touch and should be closed down
The UN programme for HIV/AIDS is out of touch with reality and hindering health capacity building, argues Roger England.
Source: BMJ
SciDev.Net
Science and Development Network
News, views and information about science, technology and the developing world
Opinions
Here is a list of the latest articles
Research deficiencies 'delaying HIV prevention'
Weaknesses in HIV research design have hindered progress in identifying prevention strategies, say Stephen W. Lagakos and Alicia R. Gable.
Source: New England Journal of Medicine
HIV/AIDS: Many challenges remain
Revised HIV/AIDS figures are a sign of better data, not that the epidemic is slowing. There is still much to be done, says Kevin De Cock.
Source: The Lancet Infectious Diseases
Development of a marketable AIDS vaccine uncertain
Twenty-five years after the discovery of HIV, there is no marketable AIDS vaccine — and it is uncertain whether there ever will be, writes Robert Steinbrook.
Source: New England Journal of Medicine
Scientists must fight Internet AIDS denialism
AIDS denial beliefs are spreading on the Internet and scientists must fight this together, say Tara C. Smith and Steven P. Novella.
Source: PLoS Medicine
Nutrition and disease debate should shift to science
Science needs to be injected into the controversy over use of nutritional supplements in tackling HIV and tuberculosis, says Wieland Gevers.
23 August 2007 | EN
Trial practitioners must become media savvy
Clinicians should learn from the alarmist media coverage that followed a recent microbicide trial, say Gita Ramjee and colleagues.
Source: PLoS Medicine
10 August 2007 | EN
Libya should end HIV medics 'charade'
Now that they have been freed, Libya should admit the innocence of medics involved in the HIV infection case, says a Nature editorial.
Source: Nature
Field trials of AIDS prevention methods must continue
Despite the political difficulties, field trials of AIDS prevention methods must be continued, argues this Nature editorial.
Source: Nature
Collaboration to kill: HIV/AIDS and TB
Developing nations must pay more than mere lip service to WHO advice on linking HIV/AIDS and tuberculosis programmes, says Peter Mugyenyi.
Backed into a corner, Thailand's action is justified
Thailand is right to take action when companies do not make essential drugs available and affordable, argue Paul Cawthorne and colleagues.
Source: The Lancet Infectious Diseases
25 June 2007 | EN
Finally, a strategy to tackle AIDS in South Africa
South Africa's long-awaited strategy to tackle AIDS is sound, but may face technical and bureaucratic obstacles, says a Nature editorial.
Source: Nature
4 May 2007 | EN
Global effort needed to fight TB
All countries need to take responsibility for fighting tuberculosis if the disease is to be eradicated, says an editorial in The Lancet.
Source: The Lancet
HIV research needs a consultation forum
The failure of another HIV microbicide trial highlights the need for better vetting measures and dialogue, says a Nature editorial.
Source: Nature
Nigerian AIDS public-private partnership praised
Public-private partnerships to limit the spread of AIDS in Africa should be commended, says a Nature editorial.
Source: Nature
11 January 2007 | EN
Libyan trial overshadows important issues
An editorial in Nature says science, not politics, drives protests against Libya's death sentence for health workers.
Source: Nature
The right diagnosis for developing world?
Health organisations and policymakers should work together to improve diagnostic tests for the major diseases in the developing world.
Source: Nature
7 December 2006 | EN
A plea for justice: Nobel Laureates write to Gaddafi
Richard Roberts and 113 fellow Nobel Laureates express their concern over the injustice of the trial of six foreign medics in Libya.
Source: Nature
Myths cloud efforts to control HIV/AIDS in Asia
Peter Godwin and colleagues outline five misconceptions that are hindering action on HIV/AIDS in Asia.
Source: PLoS Medicine
12 October 2006 | EN
Who wants an HIV vaccine?
More reliable estimates of the demand for an HIV vaccine are urgently needed to help speed vaccine development and access, say Robert Hecht and Chutima Suraratdecha.
Source: PLoS Medicine
